BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 8258339)

  • 1. Enhancement of disease by neutralizing antiviral antibodies in the absence of primed antiviral cytotoxic T cells.
    Battegay M; Kyburz D; Hengartner H; Zinkernagel RM
    Eur J Immunol; 1993 Dec; 23(12):3236-41. PubMed ID: 8258339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impairment and delay of neutralizing antiviral antibody responses by virus-specific cytotoxic T cells.
    Battegay M; Moskophidis D; Waldner H; Bründler MA; Fung-Leung WP; Mak TW; Hengartner H; Zinkernagel RM
    J Immunol; 1993 Nov; 151(10):5408-15. PubMed ID: 7693811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunity to viruses in B cell-deficient mice: influence of antibodies on virus persistence and on T cell memory.
    Bründler MA; Aichele P; Bachmann M; Kitamura D; Rajewsky K; Zinkernagel RM
    Eur J Immunol; 1996 Sep; 26(9):2257-62. PubMed ID: 8814275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An acquired immune suppression in mice caused by infection with lymphocytic choriomeningitis virus.
    Roost H; Charan S; Gobet R; Rüedi E; Hengartner H; Althage A; Zinkernagel RM
    Eur J Immunol; 1988 Apr; 18(4):511-8. PubMed ID: 2452742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lysis of infected cells in vivo by antiviral cytolytic T cells demonstrated by release of cell internal viral proteins.
    Kyburz D; Speiser DE; Battegay M; Hengartner H; Zinkernagel RM
    Eur J Immunol; 1993 Jul; 23(7):1540-5. PubMed ID: 8325330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-viral protection and prevention of lymphocytic choriomeningitis or of the local footpad swelling reaction in mice by immunization with vaccinia-recombinant virus expressing LCMV-WE nucleoprotein or glycoprotein.
    Hany M; Oehen S; Schulz M; Hengartner H; Mackett M; Bishop DH; Overton H; Zinkernagel RM
    Eur J Immunol; 1989 Mar; 19(3):417-24. PubMed ID: 2468501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biology of cloned cytotoxic T lymphocytes specific for lymphocytic choriomeningitis virus. VI. Migration and activity in vivo in acute and persistent infection.
    Byrne JA; Oldstone MB
    J Immunol; 1986 Jan; 136(2):698-704. PubMed ID: 2416821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunosuppression by lymphocytic choriomeningitis virus infection: competent effector T and B cells but impaired antigen presentation.
    Althage A; Odermatt B; Moskophidis D; Kündig T; Hoffman-Rohrer U; Hengartner H; Zinkernagel RM
    Eur J Immunol; 1992 Jul; 22(7):1803-12. PubMed ID: 1623925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells.
    Moskophidis D; Lechner F; Pircher H; Zinkernagel RM
    Nature; 1993 Apr; 362(6422):758-61. PubMed ID: 8469287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective CTL-dependent immunity and enhanced immunopathology in mice immunized by particle bombardment with DNA encoding an internal virion protein.
    Zarozinski CC; Fynan EF; Selin LK; Robinson HL; Welsh RM
    J Immunol; 1995 Apr; 154(8):4010-7. PubMed ID: 7706740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of virus and host variables in virus persistence or immunopathological disease caused by a non-cytolytic virus.
    Moskophidis D; Battegay M; van den Broek M; Laine E; Hoffmann-Rohrer U; Zinkernagel RM
    J Gen Virol; 1995 Feb; 76 ( Pt 2)():381-91. PubMed ID: 7531218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunopathological basis of lymphocytic choriomeningitis virus-induced chorioretinitis and keratitis.
    Zinkernagel MS; Bolinger B; Krebs P; Onder L; Miller S; Ludewig B
    J Virol; 2009 Jan; 83(1):159-66. PubMed ID: 18945766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of protective cytotoxic T cell responses in the presence of high titers of virus-neutralizing antibodies: implications for passive and active immunization.
    Seiler P; Bründler MA; Zimmermann C; Weibel D; Bruns M; Hengartner H; Zinkernagel RM
    J Exp Med; 1998 Feb; 187(4):649-54. PubMed ID: 9463415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction or prevention of immunopathological disease by cloned cytotoxic T cell lines specific for lymphocytic choriomeningitis virus.
    Baenziger J; Hengartner H; Zinkernagel RM; Cole GA
    Eur J Immunol; 1986 Apr; 16(4):387-93. PubMed ID: 3084281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional analysis of T lymphocyte subsets in antiviral host defense.
    Leist TP; Cobbold SP; Waldmann H; Aguet M; Zinkernagel RM
    J Immunol; 1987 Apr; 138(7):2278-81. PubMed ID: 2435794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-affinity cytotoxic T-lymphocytes require IFN-gamma to clear an acute viral infection.
    Von Herrath MG; Coon B; Oldstone MB
    Virology; 1997 Mar; 229(2):349-59. PubMed ID: 9126248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD2-deficient mice generate virus-specific cytotoxic T lymphocytes upon infection with lymphocytic choriomeningitis virus.
    Evans CF; Rall GF; Killeen N; Littman D; Oldstone MB
    J Immunol; 1993 Dec; 151(11):6259-64. PubMed ID: 7902375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early antibodies specific for the neutralizing epitope on the receptor binding subunit of the lymphocytic choriomeningitis virus glycoprotein fail to neutralize the virus.
    Eschli B; Zellweger RM; Wepf A; Lang KS; Quirin K; Weber J; Zinkernagel RM; Hengartner H
    J Virol; 2007 Nov; 81(21):11650-7. PubMed ID: 17699567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modelling the dynamics of LCMV infection in mice: conventional and exhaustive CTL responses.
    Bocharov GA
    J Theor Biol; 1998 Jun; 192(3):283-308. PubMed ID: 9650288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maintenance of memory CTL responses by T helper cells and CD40-CD40 ligand: antibodies provide the key.
    Bachmann MF; Hunziker L; Zinkernagel RM; Storni T; Kopf M
    Eur J Immunol; 2004 Feb; 34(2):317-26. PubMed ID: 14768036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.